The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
rituximab Mantle cell lymphoma 4
RITUXIMAB Meningitis tuberculous 4
RITUXIMAB Mixed dementia 4
rituximab Myositis 4
RITUXIMAB Neoplasm progression 4
Rituximab Nephrotic syndrome 4
RITUXIMAB Nervous system disorder 4
Rituximab Oedema 4
Rituximab Oral pain 4
Rituximab Osteonecrosis 4
Rituximab Pancreatitis 4
Rituximab Peripheral venous disease 4
Rituximab Peritoneal tuberculosis 4
Rituximab Pneumonia aspiration 4
Rituximab Pneumonia bacterial 4
RITUXIMAB Pneumonia klebsiella 4
Rituximab Pneumonitis 4
Rituximab Primary mediastinal large B-cell lymphoma recurrent 4
Rituximab Radicular pain 4
Rituximab Respiratory distress 4

Total Records: 1,104     Number of Pages: 56